Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 587 of 1,261
  1. CA 3025863

    COMPOSE PHARMACEUTIQUE CONTENANT DU CEFUROXIME

    ACRAF [IT] · Granted Jan 11, 2018 · Expires Jan 6, 2038

    granted
  2. US 9862928

    Generation of natural killer cells and lymphoid tissue inducer-like (LTi-like) NK-22 cells

    Regents of the University of Minnesota · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  3. US 9861691

    Norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  4. US 9861617

    Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

    PTC THERAPEUTICS, INC. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  5. US 9861705

    Conjugates of an IL-2 moiety and a polymer

    Nektar Therapeutics · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  6. US 9862761

    Composition and method for preventing or treating a tauopathy

    Northwestern University · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  7. US 9861590

    Self-supporting films for delivery of therapeutic agents

    Covidien LP · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  8. US 9862946

    Peptide oligonucleotide conjugates

    Sarepta Therapeutics, Inc. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  9. US 9862748

    Peptide compounds and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  10. US 9862746

    Compositions and methods relating to hindering DOT1L recruitment by MLL-fusion proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  11. US 9862724

    Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  12. US 9862693

    Compounds and methods of treating cancer

    The Regents of the University of California · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  13. US 9862684

    Modulation of K2P channels

    The Regents of the University of California · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  14. US 9862679

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  15. US 9861515

    Compositions and methods relating to an occlusive polymer hydrogel

    Revolution Contraceptives LLC · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  16. US 9862708

    Pyrazolone compounds and uses thereof

    TEMPEST THERAPEUTICS, INC. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  17. US 9861695

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  18. US 9861621

    LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

    Biomed Valley Discoveries, Inc. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  19. US 9861681

    Therapeutic compositions for neutralizing type I interferons, and methods of use

    The United States of America as represented by the Secretary of the Army, on behalf of the United States Army Medical Research Institute of Infectious Diseases · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  20. US 9861683

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  21. US 9861614

    Nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  22. US 9861606

    Therapeutic for treating inflammatory lung disorders

    University College Cardiff Consultants Limited · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  23. US 9861600

    Methods and compositions for treating and identifying compounds to treat age-related macular degeneration treatment

    Arizona Board of Regents, A Body Corporate Of The State Of Arizona Acting For An On Behalf Of The University of Arizona · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted
  24. US 2018000900

    COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

    GANYMED PHARMACEUTICALS AG [DE] · Granted Jan 4, 2018 · Expires Dec 30, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.